ストックスクリーナーアプリを入手
4.09
2.39%
-0.10
アフターアワーズ：
4.14
0.05
+1.22%
Pyxis Oncology Inc (PYXS) 最新ニュース
Brokerages Set Pyxis Oncology, Inc. (NASDAQ:PYXS) Price Target at $9.57 - MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Up 19.3% in October - MarketBeat
Pyxis Oncology FY2024 EPS Forecast Lowered by HC Wainwright - MarketBeat
FY2024 EPS Estimates for Pyxis Oncology Reduced by Analyst - MarketBeat
Laurion Capital Management LP Adjusts Stake in Pyxis Oncology Inc - GuruFocus.com
Pyxis Oncology Inc (PYXS) Quarterly 10-Q Report - Quartzy
Pyxis Oncology to Host In-Person and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201 - Marketscreener.com
Pyxis Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pyxis Oncology reports Q3 EPS (35c), consensus (31c) - TipRanks
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024 - The Manila Times
Pyxis Oncology Reports Strong Cash Position, Clinical Progress in Q3 Update | PYXS Stock News - StockTitan
Pyxis Oncology to host investor event to present preliminary PYX-201 data - TipRanks
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor - GlobeNewswire
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201 - Marketscreener.com
Pyxis Oncology to Reveal Key Phase 1 Trial Data for Novel Cancer Drug PYX-201 | PYXS Stock News - StockTitan
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside - AOL
Pyxis Oncology (NASDAQ:PYXS) Now Covered by Analysts at Stephens - MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Bought by abrdn plc - MarketBeat
Pyxis Oncology Inc (PYXS) Stock Price & Chart | Trade Now - Capital.com
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of “Buy” from Analysts - Defense World
Pyxis Oncology expands equity plan by 5.5 million shares - Investing.com India
Pyxis Oncology Q3 EPS Estimate Reduced by Leerink Partnrs - MarketBeat
Financial Metrics Exploration: Understanding Pyxis Oncology Inc (PYXS) Through Ratios - The Dwinnex
Examining Pyxis Oncology Inc (PYXS) stock is warranted - US Post News
Millennium Management LLC Buys 743,499 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - MarketBeat
Upward Trajectory: Pyxis Oncology Inc (PYXS) Posts a Slidee, Closing at 3.51 - The Dwinnex
Pyxis Oncology's SWOT analysis: ADC developer's stock faces pivotal readout - Investing.com
Rhumbline Advisers Takes Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Blue Owl Capital Holdings LP Purchases New Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS) - MarketBeat
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS) - PR Newswire
ShiftPixy stock plunges to 52-week low at $0.9 amid market challenges - Investing.com
Prepare Yourself for Liftoff: Pyxis Oncology Inc (PYXS) - SETE News
Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Bought by Bank of New York Mellon Corp - MarketBeat
ShiftPixy, Inc. Announces Reverse Stock Split Effective Date - Business Wire
Are Pyxis Oncology Inc’shares a good deal? - US Post News
Pyxis Oncology (NASDAQ:PYXS) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat
Market Insights: Pyxis Oncology Inc (PYXS)’s Notable Gain of 1.39, Closing at 3.66 - The Dwinnex
Earth Science Tech (OTCMKTS:ETST) vs. Pyxis Oncology (NASDAQ:PYXS) Head-To-Head Comparison - Defense World
Moment Of Truth Approaches For Pyxis Oncology (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology : Morgan Stanley 22nd Annual Global Healthcare Conference - Marketscreener.com
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - SETE News
Have you been able to find a good deal on Pyxis Oncology Inc’s shares? - US Post News
Quarterly Snapshot: Quick and Current Ratios for Pyxis Oncology Inc (PYXS) - The Dwinnex
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire
JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com
PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 - MSN
Market Momentum Report: Pyxis Oncology Inc (PYXS)’s Positive Close at 3.62 - The Dwinnex
Q3 2024 EPS Estimates for Pyxis Oncology, Inc. Boosted by William Blair (NASDAQ:PYXS) - MarketBeat
What is the investor’s view on Pyxis Oncology Inc (PYXS)? - US Post News
Cetera Advisors LLC Makes New $100,000 Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Q3 2024 Earnings Estimate for Pyxis Oncology, Inc. (NASDAQ:PYXS) Issued By William Blair - Defense World
Vanguard Group Inc. Acquires 94,740 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):